Breaking News
Get 40% Off 0
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas tool Copy Portfolios
Close

Nautilus Biotechnology Inc (NAUT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Nautilus Biotechnology's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.851 -0.009    -0.30%
19:21:43 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 117,822
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.851 - 2.940
Type:  Equity
Market:  United States
Nautilus Biotechnology 2.851 -0.009 -0.30%

Nautilus Biotechnology Company Profile

 
Read the Nautilus Biotechnology Inc company profile to learn more about the business and the management team. View Nautilus Biotechnology Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

160

Equity Type

ORD

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Contact Information

Address 2701 Eastlake Avenue East
Seattle, 98102
United States
Phone 206 333 2001
Fax -

Top Executives

Name Age Since Title
Ruedi Aebersold - - Member of Scientific Advisory Board
Lee H. Hartwell - - Member of Scientific Advisory Board
Melissa B. Epperly 43 2021 Independent Director
Farzad Nazem 59 2021 Independent Director
Joshua LaBaer - - Member of Scientific Advisory Board
Matthew McIlwain 56 2021 Independent Director
Michael Seth Altman 39 2021 Independent Director
Matthew L. Posard 54 2021 Independent Chairman of the Board
Emma Lundberg - 2021 Member of Scientific Advisory Board
Vijay Satyanand Pande 50 2021 Independent Director
Sujal M. Patel 47 2021 Co-Founder, CEO, President, Secretary & Director
Parag Mallick 44 2021 Co-Founder, Chief Scientist & Director
Karen Akinsanya 54 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NAUT Price Commentary

Write your thoughts about Nautilus Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email